AT Bancorp purchased a new position in shares of INC Research Holdings Inc. (NASDAQ:INCR) during the third quarter, Holdings Channel reports. The fund purchased 27,572 shares of the company’s stock, valued at approximately $1,229,000. AT Bancorp owned 0.05% of INC Research Holdings as of its most recent SEC filing.

A number of other large investors have also added to or reduced their stakes in the stock. Vanguard Group Inc. boosted its stake in INC Research Holdings by 29.8% in the second quarter. Vanguard Group Inc. now owns 4,732,938 shares of the company’s stock worth $180,467,000 after buying an additional 1,087,652 shares during the period. JPMorgan Chase & Co. boosted its stake in INC Research Holdings by 2,867.5% in the second quarter. JPMorgan Chase & Co. now owns 2,360,478 shares of the company’s stock worth $90,005,000 after buying an additional 2,280,933 shares during the period. BlackRock Fund Advisors boosted its stake in INC Research Holdings by 64.0% in the second quarter. BlackRock Fund Advisors now owns 1,690,162 shares of the company’s stock worth $64,446,000 after buying an additional 659,355 shares during the period. Silvercrest Asset Management Group LLC boosted its stake in INC Research Holdings by 25.7% in the second quarter. Silvercrest Asset Management Group LLC now owns 1,467,019 shares of the company’s stock worth $55,938,000 after buying an additional 299,588 shares during the period. Finally, BlackRock Institutional Trust Company N.A. boosted its stake in INC Research Holdings by 39.3% in the second quarter. BlackRock Institutional Trust Company N.A. now owns 1,073,119 shares of the company’s stock worth $40,918,000 after buying an additional 302,783 shares during the period. Institutional investors own 97.87% of the company’s stock.

Institutional Ownership by Quarter for INC Research Holdings (NASDAQ:INCR)

INC Research Holdings Inc. (NASDAQ:INCR) remained flat at $50.00 during mid-day trading on Tuesday. INC Research Holdings Inc. has a 1-year low of $34.19 and a 1-year high of $57.11. The company’s 50 day moving average is $47.26 and its 200-day moving average is $44.06. The firm has a market capitalization of $2.68 billion, a price-to-earnings ratio of 26.54 and a beta of 1.78.

INC Research Holdings (NASDAQ:INCR) last issued its quarterly earnings results on Monday, October 31st. The company reported $0.64 earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of $0.63 by $0.01. INC Research Holdings had a return on equity of 49.42% and a net margin of 6.58%. The company had revenue of $259.56 million for the quarter, compared to the consensus estimate of $259.89 million. During the same quarter in the prior year, the business earned $0.58 EPS. INC Research Holdings’s revenue was up 10.7% on a year-over-year basis. Equities research analysts predict that INC Research Holdings Inc. will post $2.50 EPS for the current fiscal year.

WARNING: “AT Bancorp Purchases New Stake in INC Research Holdings Inc. (INCR)” was originally posted by Daily Political and is owned by of Daily Political. If you are accessing this article on another website, it was illegally stolen and republished in violation of U.S. & international trademark & copyright law. The legal version of this article can be read at http://www.dailypolitical.com/2016/11/29/at-bancorp-purchases-new-stake-in-inc-research-holdings-inc-incr.html.

INCR has been the subject of a number of research analyst reports. Zacks Investment Research cut INC Research Holdings from a “buy” rating to a “hold” rating in a research note on Wednesday, November 23rd. Jefferies Group reduced their price objective on INC Research Holdings from $56.00 to $55.00 and set a “buy” rating for the company in a research note on Wednesday, August 17th. Finally, Goldman Sachs Group Inc. restated a “conviction-buy” rating and issued a $82.00 price objective on shares of INC Research Holdings in a research note on Thursday, September 8th. Four investment analysts have rated the stock with a hold rating, three have assigned a buy rating and one has given a strong buy rating to the stock. The company has an average rating of “Buy” and a consensus target price of $55.86.

In other news, CAO Christopher L. Gaenzle sold 4,734 shares of the stock in a transaction dated Wednesday, September 14th. The stock was sold at an average price of $43.14, for a total value of $204,224.76. Following the transaction, the chief accounting officer now owns 19,252 shares in the company, valued at approximately $830,531.28. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, CEO D. Jamie Macdonald sold 53,970 shares of the stock in a transaction dated Tuesday, September 27th. The shares were sold at an average price of $44.30, for a total value of $2,390,871.00. Following the completion of the transaction, the chief executive officer now owns 62,220 shares in the company, valued at approximately $2,756,346. The disclosure for this sale can be found here. Company insiders own 1.70% of the company’s stock.

About INC Research Holdings

INC Research Holdings, Inc is a global contract research organization (CRO). The Company is focused on Phase I to Phase IV clinical development services for the biopharmaceutical and medical device industries. The Company operates through two segments: Clinical Development Services and Phase I Services.

5 Day Chart for NASDAQ:INCR

Want to see what other hedge funds are holding INCR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for INC Research Holdings Inc. (NASDAQ:INCR).

Receive News & Ratings for INC Research Holdings Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for INC Research Holdings Inc. and related companies with MarketBeat.com's FREE daily email newsletter.